Start by asking what was measured
Lean mass includes non-fat tissues and is not a direct measure of muscle strength or physical performance. Headlines that substitute muscle for every change in lean mass can overstate what a scan establishes. A body-composition result is useful, but it needs to be interpreted alongside function, nutrition and the clinical context.
Source: 2025 multisociety advisory: nutrition during GLP-1 therapy
What the STEP 1 exploratory analysis reported
The STEP 1 body-composition analysis included 140 participants assessed by DXA. With semaglutide, total fat mass decreased 19.3% and lean body mass decreased 9.7% from baseline; lean mass as a proportion of total body weight increased 3.0 percentage points. Those values describe different denominators. The 9.7% figure is a change in measured lean mass, not the fraction of all weight lost that was muscle.
Why the substudy does not settle every question
This was an exploratory body-composition analysis rather than a trial designed to prove a particular muscle-preservation program. It does not tell an individual how much muscle they will lose, and it does not establish that a supplement prevents that loss. Group averages and changes measured by DXA cannot substitute for a clinician’s assessment of new weakness or difficulty with ordinary activities.
What the nutrition advisory emphasizes
A 2025 joint advisory from four professional organizations emphasizes nutritional assessment, managing reduced intake and gastrointestinal symptoms, and preserving muscle and bone through appropriate diet and resistance training. It is guidance assembled from evidence, not a randomized comparison of every possible eating or exercise plan. Protein intake should be considered within an individualized nutrition plan rather than assumed sufficient by itself.
Source: 2025 multisociety advisory: nutrition during GLP-1 therapy
Bring functional questions to follow-up
Ask your clinician what changes in strength, intake or day-to-day function should prompt contact. Discuss whether a dietitian or appropriately supervised resistance exercise would help with your circumstances. If kidney disease, limited mobility or other conditions affect your needs, a generic online target may be unsuitable. This guide does not prescribe a protein amount or exercise schedule.
Compare support without mistaking it for an outcome
When evaluating a service, ask whether nutrition care is included, who provides it, how often it is available and what it costs. A provider’s mention of nutrition support is not proof that it prevents muscle loss. Our reviews distinguish advertised service features from measured outcomes; use them to clarify what you are buying, then discuss a suitable care plan with a qualified professional.
Put the questions to work
Compare our researched providers or build your provider checklist.
Explore relevant provider reviews
Use these reviews to compare the published services and terms. Inclusion is a research starting point, not a recommendation for treatment.
Continue your research
Sources & scope
Sources checked October 12, 2026. This guide explains published information and consumer research questions; it is not a clinical evaluation.
- STEP 1 exploratory body-composition analysis
- 2025 multisociety advisory: nutrition during GLP-1 therapy
Prices and terms can change. Confirm your specific offer directly with the provider.